Stock Scorecard
Stock Summary for Kura Oncology Inc (KURA) - $10.37 as of 7/23/2026 8:31:01 AM EST
Total Score
7 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for KURA
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for KURA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for KURA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for KURA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for KURA (32 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for KURA
Financial Details for KURA
Company Overview |
|
|---|---|
| Ticker | KURA |
| Company Name | Kura Oncology Inc |
| Country | USA |
| Description | Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 8/6/2026 |
Stock Price History |
|
| Last Day Price | 10.37 |
| Price 4 Years Ago | 12.41 |
| Last Day Price Updated | 7/23/2026 8:31:01 AM EST |
| Last Day Volume | 1,217,903 |
| Average Daily Volume | 1,653,858 |
| 52-Week High | 12.49 |
| 52-Week Low | 5.45 |
| Last Price to 52 Week Low | 90.28% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 36.53 |
| Sector PE | 103.31 |
| 5-Year Average PE | -6.77 |
| Free Cash Flow Ratio | 23.57 |
| Industry Free Cash Flow Ratio | 26.98 |
| Sector Free Cash Flow Ratio | 34.79 |
| Current Ratio Most Recent Quarter | 6.15 |
| Total Cash Per Share | 0.44 |
| Book Value Per Share Most Recent Quarter | 1.22 |
| Price to Book Ratio | 8.78 |
| Industry Price to Book Ratio | 5.08 |
| Sector Price to Book Ratio | 19.24 |
| Price to Sales Ratio Twelve Trailing Months | 13.49 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.87 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.99 |
| Analyst Buy Ratings | 12 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 88,774,000 |
| Market Capitalization | 920,586,380 |
| Institutional Ownership | 97.16% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -60.17% |
| Reported EPS 12 Trailing Months | -3.42 |
| Reported EPS Past Year | -0.83 |
| Reported EPS Prior Year | -3.18 |
| Net Income Twelve Trailing Months | -294,570,000 |
| Net Income Past Year | -278,666,000 |
| Net Income Prior Year | -173,983,000 |
| Quarterly Revenue Growth YOY | 29.50% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -431.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 39,083,000 |
| Total Cash Past Year | 149,099,000 |
| Total Cash Prior Year | 224,462,000 |
| Net Cash Position Most Recent Quarter | 29,334,000 |
| Net Cash Position Past Year | 139,388,000 |
| Long Term Debt Past Year | 9,711,000 |
| Long Term Debt Prior Year | 6,916,000 |
| Total Debt Most Recent Quarter | 9,749,000 |
| Equity to Debt Ratio Past Year | 0.95 |
| Equity to Debt Ratio Most Recent Quarter | 0.92 |
| Total Stockholder Equity Past Year | 174,135,000 |
| Total Stockholder Equity Prior Year | 413,640,000 |
| Total Stockholder Equity Most Recent Quarter | 107,883,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -84,459,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.95 |
| Free Cash Flow Past Year | -70,696,000 |
| Free Cash Flow Prior Year | 133,845,000 |
Options |
|
| Put/Call Ratio | 0.13 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.52 |
| MACD Signal | 0.49 |
| 20-Day Bollinger Lower Band | 7.38 |
| 20-Day Bollinger Middle Band | 9.56 |
| 20-Day Bollinger Upper Band | 11.73 |
| Beta | 0.35 |
| RSI | 55.00 |
| 50-Day SMA | 9.28 |
| 150-Day SMA | 12.12 |
| 200-Day SMA | 12.22 |
System |
|
| Modified | 7/23/2026 2:27:11 AM EST |